论文部分内容阅读
目的分析急性心肌梗死(AMI)患者体内胰岛素抵抗情况与疾病预后的关系和临床意义。方法根据2003年1月至2007年6月保定市第一医院急诊科122例 AMI 患者的临床常规治疗情况将其分为死亡组(A组)、心功能不全组(B 组)和痊愈组(C 组),分别检测其空腹血糖及胰岛素,并计算其相应的胰岛素抵抗指数。结果死亡组(A 组)胰岛素抵抗指数明显高于心功能不全组(B 组)(P<0.05);心功能不全组(B 组)胰岛素抵抗指数明显高于痊愈组(C 组)(P<0.05)。结论 AMI 患者入院时胰岛素抵抗情况可以作为预测 AMI 患者预后的标志性检测指标。
Objective To analyze the relationship between insulin resistance and prognosis in patients with acute myocardial infarction (AMI) and its clinical significance. Methods According to the clinical routine treatment of 122 AMI patients in emergency department of Baoding First Hospital from January 2003 to June 2007, the patients were divided into three groups: death group (A group), cardiac insufficiency group (B group) and recovery group Group C), respectively, the fasting blood glucose and insulin were measured, and calculate the corresponding insulin resistance index. Results The insulin resistance index of death group (group A) was significantly higher than that of cardiac dysfunction group (group B) (P <0.05). Insulin resistance index of cardiac dysfunction group (group B) was significantly higher than that of recovery group (group C) (P < 0.05). Conclusion The insulin resistance status of patients with AMI on admission can be used as a landmark detection index to predict the prognosis of AMI patients.